GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Eager Eagle@lemmy.worldEnglish
    7·
    1 year ago

    in fact regulation IS the way to prevent this kind of discrimination, otherwise these companies can just start demanding genetic tests to rule out predisposition, regardless of the previous existence of a database with this data or their access to it.